| ACT |
Acceptance and Commitment Therapy |
| ADHD |
Attention-Deficit/Hyperactivity Disorder |
| AOD |
Alcohol and Other Drugs |
| ASPD |
Antisocial Personality Disorder |
| ASRS |
Adult ADHD Self-Report Scale |
| ASSIST |
Alcohol, Smoking and Substance Involvement Screening Test |
| AUDIT |
Alcohol Use Disorders Identification Test |
| BDI |
Beck Depression Inventory |
| BMI |
Body Mass Index |
| BPD |
Borderline Personality Disorder |
| CAN |
Camberwell Assessment of Need |
| CANSAS |
Camberwell Assessment of Need Short Appraisal Schedule |
| CBT |
Cognitive Behaviour Therapy |
| CBT-E |
CBT-Enhanced |
| CIDI |
Composite International Diagnostic Interview |
| CPT |
Cognitive Processing Therapy |
| CPTSD |
Complex PTSD |
| CVD |
Cardiovascular Disease |
| DASS |
Depression Anxiety Stress Scale |
| DAST-10 |
Drug Abuse Screening Test-10 |
| DBT |
Dialectical Behavioural Therapy |
| DBT-S |
Modified DBT |
| DDP |
Dynamic Deconstructive Psychotherapy |
| DFST |
Dual Focus Schema Therapy |
| DSM |
Diagnostic and Statistical Manual of Mental Disorders |
| DUDIT |
Drug Use Disorders Identification Test |
| ECT |
Eating Disorders |
| ED |
Eating Disorder Examination |
| EDE |
Electroconvulsive Therapy |
| EDE-Q |
Eating Disorder Examination-Questionnaire |
| EMDR |
Eye Movement Desensitisation and Reprocessing |
| ERP |
Exposure Response Therapy |
| FBT |
Family-Based Treatment |
| GAD |
Generalised Anxiety Disorder |
| GHQ |
General Health Questionnaire |
| GP |
General Practitioner |
| ICAT |
Integrative Cognitive-Affective Therapy |
| ICBT |
Integrated CBT |
| ICD |
International Classification of Diseases |
| IGT |
Integrated Group Therapy |
| IPDS |
Iowa Personality Disorder Screen |
| IPT |
Interpersonal Psychotherapy |
| IRIS |
Indigenous Risk Impact Screen |
| ITQ |
International Trauma Questionnaire |
| K10 |
Kessler Psychological Distress Scale |
| LAI |
Long Acting Injectable |
| LEC-5 |
Life Events Checklist for DSM-5 |
| MANTRA |
Maudsley Model of Anorexia Nervosa Treatment for Adults |
| MAOI |
Monoamine Oxidase Inhibitors |
| MAST |
Michigan Alcohol Screening Test |
| MBT |
Mentalisation Based Treatment |
| MHCC |
Mental Health Coordinating Council |
| MI |
Motivational Interviewing |
| MOCA |
Montreal Cognitive Assessment |
| NaSSA |
Noradrenaline and Specific Serotonergic Agent |
| NDIS |
National Disability Insurance Scheme |
| NHMRC |
National Health and Medical Research Council |
| NICE |
National Institute for Health and Care Excellence |
| NMDA |
N-methyl-D-aspartate |
| NRI |
Noradrenaline Reuptake Inhibitor |
| NRT |
Nicotine Replacement Therapy |
| NSMHWB |
National Survey of Mental Health and Wellbeing |
| OCD |
Obsessive-Compulsive Disorder |
| PCL-5 |
PTSD Check List for DSM-5 |
| PC-PTSD-5 |
Primary Care PTSD for DSM-5 |
| PE |
Prolonged Exposure |
| PHQ |
Patient Health Questionnaire |
| PS |
Psychosis Screener |
| PTSD |
Post Traumatic Stress Disorder |
| RANZCP |
Royal Australian and New Zealand College of Psychiatrists |
| RCT |
Randomised Controlled Trial |
| RIMA |
Reversible Inhibitor of Monoamine oxidase A |
| RRFT |
Risk Reduction through Family Therapy |
| rTMS |
Repetitive Transcranial Magnetic Stimulation |
| SAD |
Social Anxiety Disorder |
| SAK |
Suicide Assessment Kit |
| SAMHSA |
Substance Abuse and Mental Health Services Administration |
| SAPAS-SR |
Standardised Assessment of Personality – Abbreviated Scale |
| SCL-90-R |
Symptom Checklist-90-Revised |
| SNRI |
Serotonin and Noradrenaline Reuptake Inhibitor |
| SRQ |
Self-Reporting Questionnaire |
| SSCM |
Specialist Supportive Clinical Management |
| SSRI |
Selective Serotonin Reuptake Inhibitors |
| TCA |
Tricyclic Antidepressants |
| TGA |
Therapeutic Goods Administration |
| TLFB |
Timeline Follow Back |